To observe the visual changes in PCV patients receiving Conbercept treatment, so as to evaluate the effectiveness of the treatment. Changes of OCT, ICGA, quality of life and visual function would be observed and evaluated.~To observe and describe the characteristics of PCV.~To observe and describe the incidence of adverse events (AE) and serious adverse events (SAE) of Conbercept in the treatment of PCV, so as to evaluate the safety of this treatment.~To observe and descirbe the real situation and prognosis of PCV patients in our country.
To evaluate the effectiveness of Conbercept for PCV patients.~To describe the characteristics of PCV.~To describe the adverse events (AE) of Conbercept in the treatment of PCV.~Todescirbe the real situation and prognosis of PCV patients in our country.